Skip to content

Endothelial Cell Loss After Phacoemulsification Intra and Supracapsular

Endothelial Cell Loss After Phacoemulsification Intra and Supracapsular

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02535819
Acronym
PERCEPOLIS
Enrollment
294
Registered
2015-08-31
Start date
2015-06-01
Completion date
2018-05-01
Last updated
2026-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataracts

Keywords

Cataract surgery

Brief summary

Cataract is the clouding of the lens of the eye, which initially prevents clear vision and eventually progresses to blindness if left untreated. Cataract remains the leading cause of blindness and an important cause of visual impairment across the globe. Cataract surgery by ultrasonic phacoemulsification is the most common surgery practiced in France (600 000/year) Two sub-categories of phacoemulsification coexist : Endocapsulars techniques represented by Divide-and-Conquer and Phaco-Chop ; and Supracapsular techniques mainly represented by Subluxation (similar to Tilt-and-Tumble) The corneal endothelium plays an important role in maintaining the dehydrated state and the transparency of the cornea. Some degree of endothelial cell loss invariably occurs in all types of cataract surgery but the amount of endothelial cell loss may varies with the type of surgical technique The aim of the study is to evaluate the density of the central corneal endothelial cells before and after cataract surgery comparing two phacoemulsification techniques (Divide-and-Conquer vs Subluxation)

Interventions

PROCEDURESubluxation

One pole of The nucleus is hydrodissected until it lilts above the capsular bag. The tilted nucleus is rotated to face the incision and remaining half nucleus is then tumbled and emulsification continues from the opposite equator outside in until complete

Cataract nucleus is fragmented into 4 pieces then aspirated by ultrasonic vibration

Sponsors

Centre Hospitalier Régional Metz-Thionville
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female aged ≥ 18 years * Patients undergoing cataract surgery * Visual acuity Monoyer scale \<6/10e (\< +0.2 logMar) * Nuclear, cortical and posterior subcapsular cataract with normal density to severe in the LOCSIII classification

Exclusion criteria

* insulin-dependent diabetes and /or diabetic retinopathy * corneal disease: keratitis, dystrophy, corneal degeneration * Any disease of intraocular pressure * Any disease of the anterior segment * Low preoperative endothelial cell density \< 1500 c/mm² * Combined surgery (cataract + corneal transplant, cataract + glaucoma surgery, cataract +vitrectomy ...) * Risk factors for surgical per-operative complication * Pregnancy, lactation * Ward of court * Patient not covered by the Social Security scheme

Design outcomes

Primary

MeasureTime frame
Main Outcome Measures: postoperative Endothelial cell loss of the central corneal12 month

Countries

France

Contacts

PRINCIPAL_INVESTIGATORJean-Marc PERONE, MD

CHR Metz-Thionville

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 25, 2026